Vodis Pharmaceuticals (CNSX:VP) Stock Price Up 16.7%

Share on StockTwits

Vodis Pharmaceuticals Inc (CNSX:VP)’s stock price rose 16.7% on Friday . The stock traded as high as $0.04 and last traded at $0.04, approximately 938,755 shares were traded during trading. An increase of 54,670% from the average daily volume of 1,714 shares. The stock had previously closed at $0.03.

The company has a 50-day moving average of $0.03.

Vodis Pharmaceuticals Company Profile (CNSX:VP)

Vodis Pharmaceuticals Inc operates as an application stage company for producing medical marijuana. It operates in Canada and the United States. The company is based in Delta, Canada.

See Also: What is a put option?

Receive News & Ratings for Vodis Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vodis Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Moors & Cabot Inc. Decreases Holdings in Paypal Holdings Inc
Moors & Cabot Inc. Decreases Holdings in Paypal Holdings Inc
Sontag Advisory LLC Boosts Stake in JPMorgan Chase & Co.
Sontag Advisory LLC Boosts Stake in JPMorgan Chase & Co.
Invesco QQQ Trust  Holdings Boosted by Emerald Investment Partners LLC
Invesco QQQ Trust Holdings Boosted by Emerald Investment Partners LLC
Casey’s General Stores  Set to Announce Earnings on Monday
Casey’s General Stores Set to Announce Earnings on Monday
Moors & Cabot Inc. Has $1.87 Million Stock Position in Corning Incorporated
Moors & Cabot Inc. Has $1.87 Million Stock Position in Corning Incorporated
Novartis AG  Shares Acquired by Sontag Advisory LLC
Novartis AG Shares Acquired by Sontag Advisory LLC


 
© 2006-2020 Zolmax.